Hot Investor Mandate 3: Pharma Firm Seeks New Drugs in Thrombosis, Pain, Opthalmology, Rare Diseases, And More

11 May

A global pharmaceutical company headquartered in Tokyo, Japan is currently looking for partnering and in-licensing opportunities across the globe.

The firm is currently looking for innovative therapeutics targeting the following priority areas: Thrombosis & Thrombolysis, Pain, Cardio-Renal, Ophthalmology and rare diseases. Other interest areas include metabolic diseases, oncology, organ fibrosis and NAFLD/NASH, neurology, immunology, and mitochondrial disease. The firm is open to biologics or molecular targets, with an increased interest in new platform technologies. The following areas are currently out of focus: hypertension, thrombosis, dyslipidemia, psychiatric diseases, and immunodeficiency.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: